FEATURED NEWS

Lindus Health and Quotient Sciences Partner to Accelerate Drug Development from First-in-Human to Pivotal Trials

This collaboration is essential to eliminating traditional barriers in patient recruitment and reducing friction when transitioning between development stages and CRO partners, ultimately accelerating the delivery of breakthrough treatments to patients.

December 11, 2025

3

mins read

Lindus Health and Quotient Sciences Partner to Accelerate Drug Development from First-in-Human to Pivotal Trials

This collaboration is essential to eliminating traditional barriers in patient recruitment and reducing friction when transitioning between development stages and CRO partners, ultimately accelerating the delivery of breakthrough treatments to patients.

December 11, 2025

3

mins read

Running Effective DTx Studies in EU Markets, and Considerations for Cross Country Data Acceptance

2/27/24

1

mins

As more innovators join the digital therapeutics (DTx) landscape, understanding the intricacies of running clinical trials in Europe becomes increasingly essential. Tune in to discover how CROs in the DTx space help sponsors navigate these hurdles to successfully conduct clinical trials, delivering essential digital health interventions to patients faster.

Lindus Health Introduces Bespoke “All-In-One CRO for Digital Therapeutics” Solution to Companies In the Space to Streamline Clinical Trials

2/1/24

3

mins

We're introducing our All-In-One CRO solution for the digital therapeutics market.

Interview: Robert Langer backs Lindus Health’s "anti-CRO" strategy

1/30/24

3

mins

Robert Langer and Lindus Health co-founder, Meri Beckwith, sat down for a Q&A session to discuss their new partnership and future direction of the company.

Robert S. Langer, Co-Founder of Moderna, Joins Lindus Health’s Advisory Board

1/25/24

2

mins

We are thrilled to announce Robert S. Langer, co-founder of Moderna, has joined our advisory board.

Being Nimble and Tech-Forward in Clinical Trial Operations

1/24/24

1

mins

In our latest fireside chat, we sat down with Dan Gusz, Chief of Staff at Signos, to discuss some of the common challenges sponsors see when collaborating with CROs along with the benefits of being cutting-edge in technology when approaching clinical trials.

Lindus Health and Thirty Madison complete enrollment of personalized dermatology care pilot study

12/14/23

2

mins

We're excited to announce the completion of enrollment in Thirty Madison's personalized dermatology care pilot study that we're delivering.